Muscle Tissue Bank for Muscular Dystrophy

Status Completed

Clinical Trial Summary

This protocol proposes to establish gene expression profiles of muscular dystrophies for correct diagnosis and for development of experimental therapies for these diseases.

Clinical Trial Description

Muscular dystrophies are caused by mutations in more than 30 genes, some of them remaining to be identified. Phenotypically, it is known that one specific mutation can affect the expression of several other proteins causing difficulty in diagnosis. Correct genotyping is essential for diagnosis, prognosis and treatment, and relies on a complexed analysis of muscle tissues for phenotype profiles. Our research aims to understand how different gene mutations affect expression of other genes via muscle biopsy samples and establishment of phenotypic profiles for correct diagnosis of individual patients. Establishment of such information will be critical for understanding the progression of different muscular dystrophies and to devise new experimental therapies. This research will also provide vital clues for finding new genes involved in the disease process. Muscle samples may also be used to establish cell cultures for testing drugs and new therapies relevant to the treatment of the muscular dystrophies. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01950897
Study type	Observational
Source	Wake Forest University Health Sciences
Contact
Status	Completed
Phase
Start date	August 24, 2005
Completion date	June 9, 2015

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01480245` - Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy	Phase 3
Completed	`NCT01153932` - Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy	Phase 2
Completed	`NCT00027391` - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT03851107` - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities	N/A
Completed	`NCT01462292` - A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)	Phase 2
Recruiting	`NCT06094205` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	N/A
Recruiting	`NCT05724173` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Active, not recruiting	`NCT03811301` - [BrainConnexion] - Neurodevice Phase I Trial	N/A
Completed	`NCT05881122` - Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability	N/A
Completed	`NCT04154098` - Evaluation of a Textile Scapula Orthosis	N/A
Recruiting	`NCT05409079` - Schulze Muscular Dystrophy Ability Clinical Study	N/A
Enrolling by invitation	`NCT04009408` - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders	N/A
Active, not recruiting	`NCT00674843` - The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies	Phase 1
Recruiting	`NCT02109692` - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies	N/A
Active, not recruiting	`NCT04045158` - Diaphragm Ultrasound in Neuromuscular Disorders
Not yet recruiting	`NCT03508583` - Turkish Version of The Measure of Processes of Care (MPOC)
Terminated	`NCT01803412` - A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects	Phase 3
Completed	`NCT03406780` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 2